EMBL researchers use mass spectrometry data to analyze effects of cancer drugs

[News]

Researchers at EMBL's European Bioinformatics Institute (EMBL-EBI) have developed a new method for studying the targets and effects of cancer drugs using data from discovery mass spectrometry (MS) experiments.

More... (http://www.news-medical.net/news/20150911/EMBL-researchers-use-mass-spectrometry-data-to-analyze-effects-of-cancer-drugs.aspx)